Period:
Draw Mode:
| Volume | 185,297 |
|
|||||
| News | - | ||||||
| Day High | 0.78 | Low High |
|||||
| Day Low | 0.70 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Better Therapeutics Inc | BTTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0043 | -0.59% | 0.73 | 16:21:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.75 | 0.70 | 0.78 | 0.73 | 0.7343 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 709 | 185,297 | $ 0.7263629 | $ 134,593 | - | 0.589 - 2.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 208 | $ 0.73 | USD |
Better Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 23.16M | 31.73M | 3.23M | $ - | $ - | -0.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 256.90k | 0.60% |
Better Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6752 | 0.78 | 0.64 | 0.7127485 | 113,557 | 0.0548 | 8.12% |
| 1 Month | 0.93 | 0.93 | 0.64 | 0.7806124 | 194,120 | -0.20 | -21.51% |
| 3 Months | 1.12 | 1.61 | 0.589 | 1.01 | 153,837 | -0.39 | -34.82% |
| 6 Months | 1.59 | 1.61 | 0.589 | 1.06 | 85,904 | -0.86 | -54.09% |
| 1 Year | 1.81 | 2.80 | 0.589 | 1.86 | 337,545 | -1.08 | -59.67% |
| 3 Years | 10.04 | 29.40 | 0.589 | 4.85 | 1,608,127 | -9.31 | -92.73% |
| 5 Years | 10.04 | 29.40 | 0.589 | 4.85 | 1,608,127 | -9.31 | -92.73% |
Better Therapeutics Description
| Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. |